In 1987 the Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area ofthe Deutsche Forschungsgemeinschaft (DFG) classified 4-chloro-o-toluidine as a substance capable of inducing malignant tumours.' This classification was based on a communication from a chemical company reporting an increased incidence ofbladder cancer in workers engaged in the synthesis of 4-chloro-o-toluidine. 4 Recently, an increased incidence of bladder cancer has been found in another chemical plant in Germany where 4-chloroo-toluidine was used to synthesise the insecticide chlordimeform.3 In 1985 chlordimeform was classified by the DFG Commission as a III A2 compound ("compounds which in the Commission's opinion have proven so far to be unmistakably carcinogenic in animal experimentation only; namely under conditions which are comparable to those for possible exposure of a human being at the workplace, or from which such comparability can be deduced"), but Only 49 (all male) workers were involved in the synthesis of chlordimeform. Until 1990, bladder cancers were found in this group only.
Those 49 workers who had been involved in the synthesis of chlordimeform from 4-chloro-otoluidine were chosen to make up the study group. The period under investigation began with the entry Popp, Schmieding, Speck, Vahrenholz, Norpoth ofthe subject into the company's employment (1950-9, n = 17; 1960-9; n = 4; 1970-9; n = 28) and finished with the occurrence of bladder cancer (n = 7), death from other causes (n = 2), premature termination ofemployment (n = 8), or the end ofthe year 1990. The expected incidence of bladder cancer was calculated by extracting the sex and age specific incidence of bladder cancer from the cancer registers of Saarland (1988)6 and of Denmark and the former GDR (for 1978-82 in each case),7 multiplying them with the person-years under investigation at five year intervals, and then adding them. These cancer registers were chosen because no central cancer register for the Federal Republic of Germany exists until now, and because the closeness of the chemical plant to the regions of the registers made it likely that they really reflected the incidence ofcancer at the region of the chemical plant. The standard incidence rate (SIR) was the ratio of the number of cases observed (0 (7)) to the expected number (E). The 95% confidence interval (95% CI) and the significance level (p) were calculated under the assumption that the square root of0 is roughly normally distributed at a standard deviation (SD) of 0-5 when E is small. 8 The 4-chloro- aniline. This was used, however, for appreciably shorter periods and in smaller quantities than 4-chloro-o-toluidine. We consider it probable that any such exposure will be less important in the increased incidence of bladder cancer found. tNumber of cigarettes.
Incidence of bladder cancer in a cohort of workers exposed to 4-chloro-o-toluidine while synthesising chlordimeform
On the other hand the exposure to 4-chloro-otoluidine, which is not only the raw material to synthesise chlordimeform but is also a metabolite of chlordimeform in mammals,2 and possibly chlordimeform, seem to play a considerable part in the genesis of these cancers. Both 4-chloro-o-toluidine and chlordimeform have been shown to be carcinogenic in mice.' For 4-chloro-o-toludine, indications also exist for its carcinogenic potential in humans: Uebelin and Pletscher" did not find any cancers in subjects working in production of 4-chloro-otoluidine, but Muller'2 described a worker developing a lung tumour 12 years after chlorotoluidine intoxication. Another publication reported a (nonsignificant) increase in gastrointestinal and respiratory tract cancers in workers who had been exposed to 4-chloro-o-toluidine and other aromatic amines." Currie'4 mentioned the occurrence of one case of bladder tumour among nine cases of4-chloroo-toluidine intoxication; the tumour was diagnosed only three years after the haematuria and there was some doubt about the degree of exposure. Finally Stasik41' found eight cases of bladder tumours in a group of 116 persons exposed to 4-chloro-otoluidine and calculated an SIR of 72-7; the order of magnitude of the excess incidence of bladder tumours is in good agreement with our results.
Increased incidence of bladder tumours has been reported among a Chinese population living in counties where the insecticide chlordimeform has been used in agriculture for several years.'6 The evidence to support this study is limited, however, and needs further investigation.
It remains an open question whether chlordimeform is a bladder carcinogen in its own right. There is sufficient evidence, however, that its metabolite 4-chloro-o-toluidine exhibits such a potential. Therefore the same precautions used for 4- chloro-o-toluidine should be applied to chlordimeform.
The exposure and latency times (table 1) in our study are in good agreement with those found for other aromatic amines and with the results of Stasik.4" We could determine the N-acetylator phenotype in five ofthe seven cancer patients; four of them were slow acetylators. This agrees with other studies reporting an increased risk of bladder tumours caused by arylamines in slow acetylators.'7' Four of the carcinoma patients in our study were smokers and three were non-smokers; 76% of the workers in the Federal Republic of Germany are smokers or former smokers," so smoking seems not to be an important confounding factor in interpreting the results of the study.
Conclusions
In our view the results confirm that exposure to 4-chloro-o-toluidine is associated with an increased risk of developing bladder cancer. They suggest, moreover, that exposure to chlordimeform may also be a contributing factor. On the basis of published work and the fact that 4-chloro-o-toluidine is a metabolite of chlordimeform, we think that 4-chloroo-toluidine plays an essential part in the initiation of the increased incidence of bladder cancer. This conclusion agrees with recent findings that show an increased risk for bladder carcinogenesis after exposure to other monocyclic aromatic amines."
In our study some workers could not be included as they had left the production plant before 1985. We will report about the incidence of bladder cancer among these workers and about any new cases of bladder cancer in our study group in a subsequent publication.
synthesising chlordimeform.
4-chloro-o-toluidine while cohort of workers exposed to
Incidence of bladder cancer in a 
